Doctor Hila Magen – Multiple Myeloma Specialist

Dr. Hila Magen is a senior hematologist at the Institute of Hematology at Sheba Medical Center. She completed her medical studies at Tel Aviv University and specialized in internal medicine and hematology at Sheba. Dr. Magen focuses on the diagnosis and treatment of blood cancers, including multiple myeloma, lymphoma, and related conditions.

In addition to her clinical work, she is involved in research and clinical trials in the field of hematologic malignancies, with emphasis on innovative treatments such as CAR-T cell therapy and targeted therapies. Her work contributes to the development of advanced therapeutic protocols and improving outcomes for patients in Israel and abroad.

Dr. Hila Magen – Hematologist

Current Position:

Senior Hematologist, Institute of Hematology, Sheba Medical Center, Israel

Education:

MD, Tel Aviv University, Sackler Faculty of Medicine

Specializations:

Internal Medicine Residency, Sheba Medical Center
Hematology Fellowship, Sheba Medical Center

Clinical Expertise:

Multiple myeloma
Lymphoma Plasma cell dyscrasias CAR-T cell therapy and cellular immunotherapy

Academic Role:

Lecturer, Tel Aviv University, Sackler Faculty of Medicine

Research and Publications:

Active in clinical and translational research on:
CAR-T cell therapy for hematologic malignancies
Novel drug combinations for myeloma
Personalized treatment protocols in lymphoma and myeloma
Pubmed publications

Publications in international peer-reviewed journals including:

Blood Advances
Leukemia & Lymphoma
The Lancet Haematology

Professional Memberships:

Israeli Society of Hematology and Transfusion Medicine
European Hematology Association (EHA)
American Society of Hematology (ASH)